5-Amino-1MQ 10mg

Researchers who want to buy 5-Amino-1MQ for research should evaluate RUO labeling, batch-specific documentation, and analytical testing rather than consumer-facing claims. PubChem lists 5-Amino-1MQ as 5-amino-1-methylquinolinium, a small molecule with formula C10H11N2+ and computed molecular weight 159.21 g/mol [1]. NNMT literature describes nicotinamide N-methyltransferase as an enzyme involved in nicotinamide methylation and broader metabolic-pathway research [2]. These findings provide research context, not batch-specific product evidence.

• 5-Amino-1MQ is a small-molecule research compound studied in metabolic pathways. Its appearance in peptide-category catalogs reflects navigation, not peptide structure.

• PubChem identifies the parent cation as 5-amino-1-methylquinolinium and separately lists an iodide salt entry, so compound identity review should distinguish the listed form from any catalog specification [1], [3].

• NNMT is the accepted symbol for nicotinamide N-methyltransferase; UniProt describes the enzyme as catalyzing the N-methylation of nicotinamide using S-adenosyl-L-methionine [2].

• Published literature has examined 5-Amino-1MQ and related quinolinium analogues in NNMT inhibitor research, including enzyme selectivity, cellular models, and preclinical model design [4], [5].

• COA review should focus on compound name, lot number, purity method, identity method, date, and lab source.

• HPLC can support purity review, while LC-MS or related mass spectrometry methods can support identity verification when matched with documented reference data [6], [7].

Fast Answer: What Should Researchers Check Before They Buy 5-Amino-1MQ for Research?

To buy 5-Amino-1MQ for research, qualified research buyers should first review RUO labeling, compound identity, batch-specific COA documentation, purity testing, identity verification, lot traceability, and supplier documentation. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Literature context should support research interpretation, not product claims.

What Documentation Should Come First?

The first review layer is the product documentation set: label, COA, lot record, analytical method summary, and any supporting storage or handling record. NIST describes certificates for reference materials as documents that provide property values, uncertainty where applicable, and traceability statements, which is a useful model for thinking about why documented values matter in analytical review [8].

For a 5-Amino-1MQ research material listing, the COA should match the product name and lot number shown on the label. A mismatch between the listing, label, and batch file should be resolved before the material is selected for laboratory research.

RUO Labeling Before Procurement

RUO labeling should be visible, consistent, and aligned across the product page, label, and supporting documentation. USP notes that its reference standards are intended for test and assay applications, not direct-use contexts, which illustrates the broader distinction between analytical materials and end-use products [9].

Research procurement teams should review RUO statements as part of the documentation package. They identify the intended research scope but do not replace the COA.

What Is 5-Amino-1MQ in Research Literature?

5-Amino-1MQ is a shorthand name for 5-amino-1-methylquinolinium. PubChem lists the cation under CID 950107, while the iodide salt appears separately as NNMTi under CID 66522933, so product documentation should clearly identify the listed chemical form [1], [3].

5-Amino-1MQ is a small molecule, not a peptide. Peptide-category catalog placement does not change its chemical classification.

Compound Identity and Research Classification

5-amino-1-methylquinolinium has the IUPAC name 1-methylquinolin-1-ium-5-amine and a computed exact mass of 159.092223359 Da for the cationic structure listed by PubChem [1]. The iodide salt listing has a different molecular formula and molecular weight because it includes the counterion [3].

That distinction matters for COA review. The compound name, form, molecular weight, and analytical method should all point to the same material identity.

How Does 1MQ Naming Connect to 5-Amino-1MQ?

The “1MQ” portion refers to the 1-methylquinolinium scaffold. The “5-amino” descriptor indicates an amino substitution at the 5-position of the quinolinium ring. Medicinal chemistry literature examines this scaffold in quinolinium NNMT inhibitor research [4].

Because shorthand names can vary across suppliers and literature, researchers should compare the full compound name against PubChem, the COA, and any analytical report. This reduces ambiguity between 5-Amino-1MQ, 5 amino 1mq, and other 1MQ-related naming variants.

Catalog Amount and Compound Identity

Catalog amounts such as 50mg describe the listed quantity; they do not identify the chemical form or establish experimental conditions.

How Does 5-Amino-1MQ Fit Metabolic Pathway Research?

Published 5-Amino-1MQ work examines NNMT inhibition, nicotinamide metabolism, NAD-related cellular models, and methyl-donor pathways [5], [10].

NNMT, Nicotinamide N-Methyltransferase, and Enzyme Context

UniProt describes NNMT as catalyzing the N-methylation of nicotinamide using S-adenosyl-L-methionine, producing N1-methylnicotinamide and S-adenosyl-L-homocysteine [2]. NCBI identifies NNMT as a protein-coding gene and lists nicotinamide N-methyltransferase as the official full name [11].

This makes NNMT a relevant molecular target for research documentation. It does not make a product-use claim.

NAD-Related Models in Published Literature

Nicotinamide adenine dinucleotide, or NAD, is central to redox biology and cellular metabolism; NAD reviews describe salvage pathways that recycle nicotinamide into NAD through NAMPT and NMNAT enzymes [12]. NNMT literature is relevant because methylation of nicotinamide can intersect with how researchers model nicotinamide utilization and methyl donor balance [10].

That literature is mechanistic context. It should be interpreted as research background, not as a claim about a specific RUO material.

What Should Researchers Know About NNMT Context?

Researchers should separate three layers: NNMT enzyme biology, NNMT inhibitor literature, and the documentation for the specific 5-Amino-1MQ research material under review. The first two layers inform context; the third determines whether a product-page listing is adequately documented.

How Is NNMT Inhibition Discussed in Preclinical Models?

Medicinal chemistry work reported quinolinium analogues with low-micromolar NNMT inhibition and used structure-activity relationships to understand compound features linked with enzyme interaction [4]. A later preclinical characterization study reported that 5-amino-1MQ was evaluated for permeability, selectivity, cellular metabolite changes, and model-specific metabolic endpoints [5].

These findings remain specific to their study conditions and do not establish suitability for human, wellness, or clinical use of an RUO material.

Cellular Metabolism and Energy Pathway Terminology

NAD reviews describe NAD+ and NADH as redox cofactors involved in cellular energy metabolism, mitochondrial energy transduction, and multiple enzymatic processes [12], [13]. NNMT review literature discusses nicotinamide methylation as a pathway that can interact with methyl donor availability and NAD-related biology [10].

What Can In Vitro Models Clarify?

In vitro models can help clarify enzyme selectivity, cellular metabolite changes, and assay-specific pathway responses under controlled conditions. The 2018 5-amino-1MQ study included cell-based evaluation of intracellular 1-methylnicotinamide, NAD+, and related metabolites, which helps define research context without establishing product-use claims [5].

In vitro research is useful because it narrows the question. It does not answer every question about a compound, and it does not replace batch-specific identity testing.

How Published Literature Frames 5-Amino-1MQ Research Findings

Published literature frames 5-Amino-1MQ mainly around NNMT inhibitor chemistry, enzyme selectivity, cellular metabolism, and preclinical model interpretation [4], [5].

What Counts as Source-Quality Evidence?

Source-quality evidence starts with official databases, peer-reviewed literature, and recognized analytical guidance. PubChem and UniProt can support identity and enzyme context, while peer-reviewed studies can support model-specific statements [1], [2], [4], [5].

Vendor copy, forum posts, and anecdotal claims should not be treated as scientific evidence.

Where Should Literature Gaps Stay Visible?

Literature gaps should stay visible wherever a finding is model-specific, early-stage, or dependent on assay conditions.

Research Models in the Published Literature

Published topics include NNMT enzyme research, nicotinamide-methylation models, cellular metabolism, NAD-related pathways, and analytical compound characterization. NNMT literature and NAD metabolism reviews provide this context [5], [10], [12].

How Research Literature Stays Separate From Product Claims

A paper examines a pathway, enzyme, or model-specific endpoint. It does not establish outcomes for a supplied RUO product.

Why Should Study Findings Stay Separate From Product Claims?

Study findings should stay separate from product claims because model design, assay conditions, and analytical endpoints define the scope of each result. FDA data-integrity guidance emphasizes that records should be reliable and accurate, which supports the broader principle that data should remain traceable to the conditions under which it was generated [14].

Limits of Model-Specific Evidence

Product-performance conclusions require evidence for the specific material and experimental conditions; pathway relevance alone is insufficient.

Why Does COA Documentation Matter for 5-Amino-1MQ?

COA documentation matters because it ties a product listing to a specific batch record. NIST describes certified reference material documentation as including property values, uncertainty where applicable, and traceability information, which underscores why documentation must be specific rather than generic [8].

What Certificate of Analysis Fields Should Researchers Review?

Researchers should review compound name, lot number, reported purity, analytical method, date, laboratory source, and whether the COA matches the product label. NIST explains that a chemical Certificate of Analysis can include material description, intended purpose, certified property values, methods, validity period, and technical information [8].

A COA without a matching lot number is incomplete for procurement review. A purity number without method context is also limited.

How Does Batch-Specific Documentation Support Material Review?

Batch-specific documentation supports material review by connecting the tested sample to the material being evaluated. NIST notes that Standard Reference Materials are supplied with a Certificate of Analysis and related documentation when applicable, which shows the value of connecting material identity with documented measurement records [15].

For 5-Amino-1MQ, the same logic applies at the product-page level. The lot number on the label, COA, and supplier record should tell the same story.

Research Use Statements in Product Documentation

Research use statements should be clear and consistent across product documentation. They should not be hidden in fine print or contradicted by copy that implies non-RUO purposes.

Confirm that the listing, label, COA, and storage record describe the same material and research-only designation.

How Does Analytical Testing Support Compound Identity?

Analytical testing supports compound identity by adding method-based evidence to the product record. It cannot make unsupported claims, but it can help researchers evaluate whether the listed compound, label, and batch documentation are consistent.

Analytical review workflow:

1. Verify that the compound name, chemical form, and lot number match across the label, product page, and COA.

2. Review the batch-specific COA before comparing literature context.

3. Check whether the purity testing method is listed.

4. Confirm whether identity testing is supported by LC-MS, mass spectrometry, or another suitable analytical method.

5. Review chromatogram or mass data when available.

6. Check the COA date, laboratory source, and record consistency.

7. Document storage and handling requirements in a laboratory record.

How Does HPLC Support Purity Review?

HPLC supports purity review by separating components under a defined chromatographic method and reporting a purity-related result based on the method conditions. FDA’s Q2(R2) guidance describes analytical procedure validation principles that can apply to methods using chromatographic and spectroscopic data [6].

For procurement review, HPLC is strongest when the COA includes method context, chromatogram information, and batch matching. A standalone purity percentage is less informative without those details.

How Does LC-MS Support Identity Verification?

LC-MS can support identity verification by combining chromatographic separation with mass-based information. Reviews of small-molecule mass spectrometry note that identification often depends on reference spectra, molecular formula interpretation, fragmentation data, and database matching [7], [16].

For 5-Amino-1MQ, LC-MS documentation should be interpreted with the listed chemical form in mind. The parent cation and salt form have different formula records in PubChem [1], [3].

What Does Mass Spectrometry Add to Documentation?

Mass spectrometry adds mass-based evidence that can support compound identity review. Small-molecule MS literature emphasizes that structural identification can require accurate mass, isotopic patterns, fragment interpretation, and reference data rather than a single number alone [7], [16], [17].

This is why a COA should ideally show both purity and identity support. Purity and identity are related, but they are not the same question.

Lot Traceability and Supplier Documentation Review

Lot traceability helps research buyers connect the material received with the records reviewed. The more specific the documentation, the easier it is to evaluate consistency across product page, label, COA, and lab file.

Why Should Research Buyers Review Lot Numbers?

Research buyers should review lot numbers because a COA is only useful when it corresponds to the material being evaluated. NIST SRM definitions note that lot or issue identifiers can appear on certificates and help identify batch-produced or individually certified units [8].

For RUO procurement, the lot number should be checked before any literature interpretation. The literature does not verify the specific batch.

What Does Labeling Consistency Add to Procurement Review?

Labeling consistency adds confidence that the product page, label, and COA refer to the same material. FDA data-integrity guidance emphasizes reliable, accurate records, which supports the broader documentation principle that records should remain complete, consistent, and attributable [14].

A label should not create a different impression from the COA. If the label says one compound form and the COA reports another, that gap should be resolved.

How Should Researchers Evaluate 1MQ Research Material Listings?

Researchers should evaluate 1MQ research material listings by looking beyond shorthand names. The review should confirm full compound name, chemical form, PubChem identity, COA fields, purity method, identity method, lot number, and RUO language.

Catalog Specifications and Chemical Identity

Catalog specifications describe inventory details. Chemical identity separately requires the compound name, form, and analytical record.

What Should Research Buyers Confirm Before They Buy 5-Amino-1MQ for Research?

Research buyers should confirm RUO labeling, compound identity, full product name, chemical form, batch-specific COA, HPLC purity review, LC-MS or mass-based identity support, lot traceability, and storage documentation. PubChem identity records and peer-reviewed NNMT literature can support the scientific background, but batch records support procurement review [1], [3], [5].

Related Metabolic Research Compounds

Where SLU-PP-332 Belongs in Metabolic Research Context

Published SLU-PP-332 literature describes an ERR signaling chemical probe rather than an NNMT inhibitor [18]. It is not a synonym, substitute, or direct comparator for 5-Amino-1MQ.

5-Amino-1MQ belongs in NNMT and nicotinamide methylation research, while SLU-PP-332 belongs in ERR signaling literature.

Common Misunderstandings in 5-Amino-1MQ Research

Common misunderstandings usually come from mixing catalog language, literature findings, and product claims.

Why Does Peptide Labeling Require Careful Review?

Peptide labeling requires careful review because 5-Amino-1MQ may appear on peptide supplier websites even though PubChem identifies it as a small molecule cation rather than a peptide sequence [1]. The product-category label may help store navigation, but it should not override chemical identity.

How Small Molecule Classification Affects Documentation

Small molecule classification affects documentation because identity review relies on chemical name, formula, exact mass, salt form, and analytical data rather than peptide sequence confirmation. PubChem lists both parent and salt-related records, which makes chemical-form consistency especially important [1], [3].

Key distinctions:

• Published literature does not equal product-use guidance.

• Preclinical findings should not be converted into claims for RUO materials.

• A purity percentage does not prove complete compound identity.

• A COA should be batch-specific.

• Product amounts are catalog details, not evidence of chemical identity or research outcomes.

Research Procurement Checklist for 5-Amino-1MQ

A practical research procurement review should be documentation-led. Use the checklist below before evaluating a 5-Amino-1MQ research material listing.

• Verify that the compound is labeled for research use only.

• Review the batch-specific certificate of analysis.

• Confirm that purity data are supported by analytical testing.

• Check that the lot number on the COA matches the product documentation.

• Compare compound name, chemical form, molecular weight, and PubChem identity across documentation.

• Assess whether the product page avoids non-RUO claims.

• Document storage and handling conditions in a laboratory record.

What Lab Teams Should Compare Across Supplier Documentation?

Lab teams should compare the product name, synonym list, chemical form, lot number, purity result, analytical method, COA date, laboratory source, and RUO label language. FDA’s data-integrity guidance emphasizes reliable and accurate records, which supports this kind of consistency review [14].

If the supplier provides a chromatogram or mass data, the lab file should keep it with the COA. That record helps later reviewers understand how the procurement decision was made.

Final Review Before Procurement

Complete identity review, COA review, lot matching, analytical testing review, RUO labeling review, and documentation consistency checks before the procurement decision.

Pure Lab Peptides supplies compounds for laboratory research use only. Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products. Researchers are responsible for ensuring lawful, appropriate handling and use in accordance with applicable regulations and institutional guidelines.

Review the product-page documentation, COA details, and RUO labeling before evaluating this compound for laboratory research.

FAQs

What does research use only mean for 5-Amino-1MQ?

Research use only means 5-Amino-1MQ is intended for research purposes in controlled laboratory contexts.

What should researchers consider before they buy 5-Amino-1MQ for research?

Researchers should consider documentation before they buy 5-Amino-1MQ for research. Key review points include RUO labeling, batch-specific COA records, HPLC purity review, LC-MS identity support, lot traceability, and consistency between the product listing and supporting files. Procurement review should come before broader literature interpretation.

Why does 5-Amino-1MQ research focus on NNMT?

5-Amino-1MQ research focuses on NNMT because published literature has examined the compound in relation to inhibiting NNMT and the inhibition of nicotinamide N-methyltransferase in model-specific settings [5].

What does the amino group at the 5-position mean for research identification?

The amino group at the 5-position is part of 5-Amino-1MQ’s chemical description. Compare the full compound name, shorthand names, chemical form, and COA details against identity records.

How should researchers interpret 5-Amino-1MQ mechanism of action language?

Mechanistic research may include NNMT, nicotinamide methylation, NAD-related biology, nucleotide salvage, cofactor systems, energy production, and mitochondrial function. Interpret these topics within the conditions of the published studies.

Why Does the Experimental Model Matter?

Lipid-metabolism findings remain specific to the experimental model. They do not establish performance of an independently supplied research material.

---

Researchers Cited in This Guide

The researchers listed below are cited for relevant published work. Their inclusion does not imply that they wrote, reviewed, or endorsed this guide or Pure Lab Peptides products.

Harshini Neelakantan, PhD

Author profile: ASPET Profile

Harshini Neelakantan, PhD, has published research on small-molecule NNMT inhibitor characterization, enzyme assays, and model-specific 5-Amino-1MQ findings. Her publications provide background on compound identity and nicotinamide N-methyltransferase research.

Selected publications:

• A peer-reviewed 5-Amino-1MQ NNMT research model study — Biochemical Pharmacology, 2018. DOI: 10.1016/j.bcp.2017.11.007. PMID: [29155147].

• Structure–Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase — Journal of Medicinal Chemistry, 2017. DOI: 10.1021/acs.jmedchem.7b00389. PMID: [28548833].

Stanley J. Watowich, PhD

Author profile: UTMB Faculty Profile

Stanley J. Watowich, PhD, has published work on NNMT enzyme assays, small-molecule inhibitor structure–activity relationships, and biochemical model design, including enzyme-activity measurement and ligand–enzyme interactions.

Selected publications:

• Noncoupled Fluorescent Assay for Direct Real-Time Monitoring of Nicotinamide N-Methyltransferase Activity — Biochemistry, 2017. DOI: 10.1021/acs.biochem.6b01215. PMID: [28121423].

• Structure–Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase — Journal of Medicinal Chemistry, 2017. DOI: 10.1021/acs.jmedchem.7b00389. PMID: [28548833].

REFERENCES

1. National Center for Biotechnology Information. PubChem Compound Summary: 5-Amino-1-methylquinolinium. PubChem. Updated 2026.

2. UniProt Consortium. NNMT_HUMAN Nicotinamide N-methyltransferase. UniProtKB/Swiss-Prot. Accessed 2026.

3. National Center for Biotechnology Information. PubChem Compound Summary: NNMTi, 5-amino-1-methylquinolinium iodide. PubChem. Updated 2026.

4. Neelakantan H, Wang H-Y, Vance V, Hommel JD, McHardy SF, Watowich SJ. Small-molecule NNMT inhibitor structure-activity research. Journal of Medicinal Chemistry. 2017. DOI: 10.1021/acs.jmedchem.7b00389. PMID: 28548833.

5. Neelakantan H, et al. Preclinical 5-amino-1MQ NNMT inhibitor characterization study. Biochemical Pharmacology. 2018. PMID: 29155147.

6. U.S. Food and Drug Administration. Q2(R2) Validation of Analytical Procedures. FDA Guidance Document. 2024.

7. Scheubert K, Hufsky F, Böcker S. Computational mass spectrometry for small molecules. Journal of Cheminformatics. 2013. DOI: 10.1186/1758-2946-5-12.

8. National Institute of Standards and Technology. SRM Definitions. NIST. Updated 2026.

9. United States Pharmacopeia. Reference Standards FAQs. USP. Accessed 2026.

10. Pissios P. Nicotinamide N-methyltransferase review. Trends in Endocrinology & Metabolism. 2017. DOI: 10.1016/j.tem.2017.02.004. PMID: 28291578.

11. National Center for Biotechnology Information. NNMT nicotinamide N-methyltransferase gene record. NCBI Gene. Updated 2026.

12. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and cellular processes review. Nature Reviews Molecular Cell Biology. 2021.

13. Ralto KM, Rhee EP, Parikh SM. NAD(H) in mitochondrial energy transduction. Nature Reviews Nephrology. 2020.

14. U.S. Food and Drug Administration. Data Integrity and Compliance With Drug CGMP: Questions and Answers. FDA Guidance Document. 2018.

15. National Institute of Standards and Technology. Reference Materials. NIST. Accessed 2026.

16. Kind T, Fiehn O. Small-molecule structure elucidation using mass spectrometry. Bioanalytical Reviews. 2010. DOI: 10.1007/s12566-010-0015-9.

17. Neumann S, Böcker S. Identification of metabolites and small molecules from mass spectrometry data. Analytical and Bioanalytical Chemistry. 2010. DOI: 10.1007/s00216-010-4142-5.

18. Okda HE, Zhao P, Hayes M, et al. SLU-PP-332 ERR signaling structure-activity research. International Journal of Biological Macromolecules. 2026. DOI: 10.1016/j.ijbiomac.2026.151450.

---

Research Disclaimer

This material is supplied strictly for in vitro laboratory research and is not for human or veterinary use. Published studies describe specific experimental materials, models, and methods; they do not establish the safety, efficacy, or suitability of this catalog product for non-research use. Review the original publications and the lot-specific analytical documentation independently.